The pharmaceutical industry has called for abolishing “off-year” drug price revisions in the run-up to the formulation of the 2024 Basic Policy on Economic and Fiscal Management and Reform (honebuto) later in June. It appears that its lobbying efforts have…
HOME > LATEST
LATEST
-
BUSINESS Pfizer Rolls Out Single-Dose Version of COVID-19 Vaccine in Japan
May 20, 2024
-
BUSINESS Keytruda Gets Nod for Gastric, Biliary Tract Cancer in Japan
May 20, 2024
-
BUSINESS Prevymis Now Approved for CMV Prevention in Organ Transplant Recipients in Japan
May 20, 2024
-
BUSINESS Braftovi-Mektovi Combo Broadens Label to Thyroid Cancer: Ono
May 20, 2024
-
REGULATORY Expand Mixed-Billing Scheme, Use of Private Payers: LDP Healthcare Reform Team
May 20, 2024
-
BUSINESS Amylyx Pulls Out from Japan after ALS Trial Flop
May 20, 2024
-
REGULATORY MHLW’s Generic Industry Panel to Call for 5-Year Intensive Reform Period
April 26, 2024
-
REGULATORY 14 Makers Picked for Health Minister-Championed Subsidy Program for Cough Meds, Essential Drugs
April 15, 2024
-
BUSINESS Fujifilm to Invest 180 Billion Yen to Bolster Biologic CDMO Biz in North America
April 15, 2024
-
BUSINESS Astellas Slashes FY2023 Profit Forecasts on Gene Therapy Impairment Loss
April 15, 2024
-
BUSINESS Takeda Files 2-Dose Vial Version of Novavax COVID Vaccine
April 15, 2024
-
BUSINESS MSD Files Keytruda Plus Chemo for Endometrial Cancer in Japan
April 15, 2024
-
REGULATORY Japan to Discuss Orphan Designation for Cannabidiol, 2 More Drugs
April 15, 2024
-
REGULATORY Japan Might Approve 1st Eylea Biosimilar by June, but Not AMD Use
April 15, 2024
-
BUSINESS Wholesaler Purchase Prices of Unprofitable Drugs on Upward Trend after FY2024 Revision
April 12, 2024
-
BUSINESS Japan Autoimmune Drug Market Likely to Top 1 Trillion Yen in 2033: Fuji Keizai
April 12, 2024
-
BUSINESS Smallpox Drug TPOXX Filed in Japan after Govt Request
April 12, 2024
-
REGULATORY Japan Will Persistently Urge China to Release Detained Astellas Employee: Govt
April 12, 2024
-
BUSINESS Moderna, Tohoku Biobank Start Epidemiology Study on Latent Viruses
April 12, 2024
-
BUSINESS ASKA’s Birth Control Pill Makes Mark in Japan PIII Study
April 12, 2024
ページ
The pharmaceutical industry is ever-changing. Recruiters must evolve accordingly and prepare well in advance for future talent needs.This means predicting the changes and trends that will impact the market, industry, and your organization, and how this will affect talent requirements.…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…